Elevance Health Gross Margin 2012-2025 | ELV
Current and historical gross margin for Elevance Health (ELV) over the last 10 years. The current gross profit margin for Elevance Health as of September 30, 2025 is %.
| Elevance Health Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $194.82B | $29.49B | 15.14% |
| 2025-06-30 | $189.22B | $29.37B | 15.52% |
| 2025-03-31 | $183.33B | $30.08B | 16.41% |
| 2024-12-31 | $177.01B | $29.69B | 16.78% |
| 2024-09-30 | $174.22B | $30.24B | 17.36% |
| 2024-06-30 | $171.96B | $30.77B | 17.89% |
| 2024-03-31 | $171.75B | $30.02B | 17.48% |
| 2023-12-31 | $171.34B | $29.72B | 17.34% |
| 2023-09-30 | $168.62B | $29.33B | 17.39% |
| 2023-06-30 | $165.71B | $28.82B | 17.39% |
| 2023-03-31 | $160.67B | $27.84B | 17.33% |
| 2022-12-31 | $156.60B | $26.92B | 17.19% |
| 2022-09-30 | $153.25B | $26.88B | 17.54% |
| 2022-06-30 | $149.13B | $26.08B | 17.48% |
| 2022-03-31 | $144.35B | $25.78B | 17.86% |
| 2021-12-31 | $138.64B | $25.17B | 18.16% |
| 2021-09-30 | $133.88B | $24.34B | 18.18% |
| 2021-06-30 | $129.22B | $24.08B | 18.63% |
| 2021-03-31 | $124.63B | $25.09B | 20.13% |
| 2020-12-31 | $121.87B | $24.87B | 20.41% |
| 2020-09-30 | $117.45B | $24.53B | 20.89% |
| 2020-06-30 | $112.97B | $23.69B | 20.97% |
| 2020-03-31 | $109.17B | $21.20B | 19.42% |
| 2019-12-31 | $104.21B | $20.44B | 19.61% |
| 2019-09-30 | $100.18B | $20.00B | 19.96% |
| 2019-06-30 | $96.76B | $19.89B | 20.55% |
| 2019-03-31 | $94.23B | $20.10B | 21.33% |
| 2018-12-31 | $92.11B | $20.21B | 21.94% |
| 2018-09-30 | $91.41B | $19.78B | 21.64% |
| 2018-06-30 | $90.59B | $19.04B | 21.02% |
| 2018-03-31 | $90.05B | $18.31B | 20.34% |
| 2017-12-31 | $90.04B | $17.80B | 19.77% |
| 2017-09-30 | $89.07B | $17.94B | 20.14% |
| 2017-06-30 | $88.05B | $18.10B | 20.56% |
| 2017-03-31 | $87.10B | $18.26B | 20.97% |
| 2016-12-31 | $84.86B | $18.03B | 21.24% |
| 2016-09-30 | $83.34B | $17.75B | 21.30% |
| 2016-06-30 | $81.84B | $17.71B | 21.64% |
| 2016-03-31 | $80.40B | $17.87B | 22.22% |
| 2015-12-31 | $79.16B | $18.04B | 22.79% |
| 2015-09-30 | $77.95B | $18.29B | 23.47% |
| 2015-06-30 | $76.61B | $18.21B | 23.77% |
| 2015-03-31 | $75.07B | $17.75B | 23.64% |
| 2014-12-31 | $73.87B | $17.02B | 23.04% |
| 2014-09-30 | $72.79B | $16.21B | 22.27% |
| 2014-06-30 | $72.09B | $15.65B | 21.71% |
| 2014-03-31 | $71.31B | $15.16B | 21.25% |
| 2013-12-31 | $71.02B | $14.79B | 20.82% |
| 2013-09-30 | $68.44B | $14.50B | 21.18% |
| 2013-06-30 | $65.94B | $14.02B | 21.26% |
| 2013-03-31 | $63.66B | $13.47B | 21.16% |
| 2012-12-31 | $61.50B | $13.28B | 21.60% |
| 2012-09-30 | $61.49B | $13.14B | 21.36% |
| 2012-06-30 | $61.54B | $13.17B | 21.40% |
| 2012-03-31 | $61.23B | $13.04B | 21.30% |
| 2011-12-31 | $60.71B | $13.06B | 21.52% |
| 2011-09-30 | $60.02B | $13.45B | 22.40% |
| 2011-06-30 | $59.19B | $13.48B | 22.77% |
| 2011-03-31 | $58.52B | $13.74B | 23.48% |
| 2010-12-31 | $58.70B | $13.77B | 23.46% |
| 2010-09-30 | $63.03B | $17.39B | 27.59% |
| 2010-06-30 | $63.89B | $17.79B | 27.84% |
| 2010-03-31 | $64.87B | $17.78B | 27.41% |
| 2009-12-31 | $64.94B | $17.40B | 26.79% |
| 2009-09-30 | $61.05B | $13.01B | 21.32% |
| 2009-06-30 | $60.59B | $12.36B | 20.39% |
| 2009-03-31 | $60.84B | $12.51B | 20.56% |
| 2008-12-31 | $61.25B | $12.52B | 20.44% |
| 2008-09-30 | $61.75B | $13.66B | 22.11% |
| 2008-06-30 | $62.03B | $14.31B | 23.07% |
| 2008-03-31 | $61.63B | $14.47B | 23.47% |
| 2007-12-31 | $61.17B | $14.70B | 24.03% |
| 2007-09-30 | $60.20B | $14.77B | 24.53% |
| 2007-06-30 | $59.40B | $14.65B | 24.66% |
| 2007-03-31 | $58.31B | $14.47B | 24.82% |
| 2006-12-31 | $57.06B | $14.43B | 25.30% |
| 2006-09-30 | $53.82B | $13.74B | 25.54% |
| 2006-06-30 | $50.53B | $13.10B | 25.92% |
| 2006-03-31 | $47.51B | $12.37B | 26.04% |
| 2005-12-31 | $44.61B | $11.63B | 26.06% |
| 2005-09-30 | $39.97B | $10.34B | 25.88% |
| 2005-06-30 | $33.62B | $8.56B | 25.45% |
| 2005-03-31 | $27.08B | $6.90B | 25.49% |
| 2004-12-31 | $20.71B | $5.33B | 25.75% |
| 2004-09-30 | $18.29B | $4.78B | 26.15% |
| 2004-06-30 | $17.75B | $4.72B | 26.61% |
| 2004-03-31 | $17.26B | $4.62B | 26.80% |
| 2003-12-31 | $16.78B | $4.49B | 26.75% |
| 2003-09-30 | $16.48B | $4.39B | 26.66% |
| 2003-06-30 | $15.79B | $4.21B | 26.63% |
| 2003-03-31 | $14.58B | $3.83B | 26.30% |
| 2002-12-31 | $13.29B | $3.45B | 25.93% |
| 2002-09-30 | $11.95B | $3.05B | 25.51% |
| 2002-06-30 | $11.04B | $2.78B | 25.21% |
| 2002-03-31 | $10.70B | $2.68B | 25.06% |
| 2001-12-31 | $10.45B | $2.63B | 25.18% |
| 2001-09-30 | $10.10B | $2.50B | 24.78% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $82.860B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $168.076B | 30.86 |
| HCA Healthcare (HCA) | United States | $109.268B | 18.09 |
| CVS Health (CVS) | United States | $100.704B | 11.58 |
| Cencora (COR) | United States | $67.884B | 21.88 |
| Natera (NTRA) | United States | $33.085B | 0.00 |
| DiDi Global (DIDIY) | China | $23.203B | 21.43 |
| Labcorp Holdings (LH) | United States | $21.720B | 16.56 |
| Medpace Holdings (MEDP) | United States | $17.364B | 43.11 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.188B | 0.00 |
| Viatris (VTRS) | United States | $15.146B | 5.64 |
| ICON (ICLR) | Ireland | $14.921B | 14.81 |
| BioMerieux (BMXMF) | France | $14.304B | 0.00 |
| Solventum (SOLV) | United States | $13.884B | 13.48 |
| Revvity (RVTY) | United States | $12.644B | 23.28 |
| CochLear (CHEOY) | Australia | $11.671B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.650B | 20.51 |
| Avantor (AVTR) | United States | $8.441B | 12.90 |
| Sonic Healthcare (SKHHY) | Australia | $7.636B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.454B | 0.00 |
| HealthEquity (HQY) | United States | $7.313B | 27.35 |
| BrightSpring Health Services (BTSG) | United States | $6.935B | 41.34 |
| PACS (PACS) | United States | $6.185B | 37.61 |
| Bausch + Lomb (BLCO) | Canada | $6.135B | 40.28 |
| Sotera Health (SHC) | United States | $5.452B | 26.29 |
| Alignment Healthcare (ALHC) | United States | $4.351B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.022B | 53.08 |
| Concentras Parent (CON) | United States | $2.619B | 16.34 |
| Progyny (PGNY) | United States | $2.252B | 44.27 |
| Organon (OGN) | United States | $2.238B | 2.36 |
| Surgery Partners (SGRY) | United States | $1.993B | 25.68 |
| Establishment Labs Holdings (ESTA) | United States | $1.923B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.891B | 11.29 |
| Ardent Health (ARDT) | United States | $1.244B | 4.06 |
| Nutex Health (NUTX) | United States | $1.173B | 8.97 |
| Teladoc Health (TDOC) | United States | $1.173B | 0.00 |
| CareDx (CDNA) | United States | $1.045B | 17.08 |
| GoodRx Holdings (GDRX) | United States | $0.933B | 15.28 |
| Omada Health (OMDA) | United States | $0.898B | 0.00 |
| Embecta (EMBC) | United States | $0.755B | 4.29 |
| InnovAge Holding (INNV) | United States | $0.752B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.733B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| Enhabit (EHAB) | United States | $0.547B | 24.55 |
| CryoPort (CYRX) | United States | $0.545B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.481B | 0.00 |
| SBC Medicals (SBC) | United States | $0.456B | 8.40 |
| Agilon Health (AGL) | United States | $0.402B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.52 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.279B | 0.00 |
| So-Young (SY) | China | $0.272B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.255B | 53.65 |
| KindlyMD (NAKA) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.196B | 0.00 |
| LifeMD (LFMD) | United States | $0.185B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.087B | 0.00 |
| Biodesix (BDSX) | United States | $0.068B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.067B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.28 |
| Intelligent Bio Solutions (INBS) | United States | $0.019B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |